Your browser doesn't support javascript.
loading
Dental treatment in patients with severe gag reflex using propofol-remifentanil intravenous sedation
Journal of Dental Anesthesia and Pain Medicine ; : 65-69, 2017.
Article in English | WPRIM | ID: wpr-76812
ABSTRACT
Patients with severe gag reflex (SGR) have difficulty getting the treatment they require in local clinics, and many tend to postpone the start of their treatment. To address this problem, dentists have used behavioral techniques and/or pharmacological techniques for treatment. Among the pharmacological methods available, propofol IV sedation is preferred over general anesthesia because it is a simpler procedure. Propofol in combination with remifentanil is characterized by stable sedative effects and quick recovery, leading to a deep sedation. Remifentanil acts to reduce the pain caused by lipid-soluble propofol on injection. The synergistic effects of propofol-remifentanil include reduction in the total amount of drug required to achieve a desired sedation level and anti-emetic effects. In this case report, we outline how the use of propofol-remifentanil IV sedation enabled us to successfully complete a wide range of dental treatments in a patient with SGR.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Reflex / Propofol / Dental Care / Dentists / Deep Sedation / Gagging / Hypnotics and Sedatives / Anesthesia, General / Antiemetics Limits: Humans Language: English Journal: Journal of Dental Anesthesia and Pain Medicine Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Reflex / Propofol / Dental Care / Dentists / Deep Sedation / Gagging / Hypnotics and Sedatives / Anesthesia, General / Antiemetics Limits: Humans Language: English Journal: Journal of Dental Anesthesia and Pain Medicine Year: 2017 Type: Article